Article written by Bruce Sylvester Investigators from the QUAZAR trial report that treatment with oral azacytidine (CC-486), significantly improves survival in older patients, over age of 55, with… read more.
Article written by Bruce Sylvester The diabetes drug canagliflozin, which has already shown efficacy in slowing kidney disease, is also effective among patients with advanced kidney disease.
Article written by Bruce Sylvester. Rilonacept, an FDA approved drug for other inflammatory diseases, shows high efficacy for treating acute pericarditis, an inflammation of tissue around the heart.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
